Publikationen von S. Ahola

Ahola, S.; Langer, T.: Ferroptosis in mitochondrial cardiomyopathy. Trends in Cell Biology 34, S. 150 - 160 (2024)

Ahola, S.; Pazurek, L. A.; Mayer, F. C.; Lampe, P.; Hermans, S.; Becker, L.; Amarie, O. V.; Fuchs, H.; Gailus-Durner, V.; de Angelis, M. H. et al.; Riedel, D.; Nolte, H.; Langer, T.: Opa1 processing is dispensable in mouse development but is protective in mitochondrial cardiomyopathy. Science Advances 10 (2024)

Ahola, S.; Langer, T.: Ferroptosis in mitochondrial cardiomyopathy. Trends in Cell Biology (2023)

Rivera Mejias, P.; Narbona-Pérez, Á. J.; Hasberg, L.; Kroczek, L.; Bahat, A.; Lawo, S.; Folz-Donahue, K.; Schumacher, A. L.; Ahola, S.; Mayer, F. C. et al.; Giavalisco, P.; Nolte, H.; Lavandero, S.; Langer, T.: The mitochondrial protease OMA1 acts as a metabolic safeguard upon nuclear DNA damage. Cell Reports 42, 112332, S. 112332 (2023)

Ahola, S.; Rivera Mejias, P.; Hermans, S.; Chandragiri, S.; Giavalisco, P.; Nolte, H.; Langer, T.: OMA1-mediated integrated stress response protects against ferroptosis in mitochondrial cardiomyopathy. Cell Metab 34 (11), S. 1875 - 1891 e7 (2022)

Ahola, S.; Langer, T.; MacVicar, T.: Mitochondrial Proteolysis and Metabolic Control. Cold Spring Harb Perspect Biol 11 (7) (2019)

Sprenger, H.-G.; Wani, G.; Hesseling, A.; Konig, T.; Patron, M.; MacVicar, T.; Ahola, S.; Wai, T.; Barth, E.; Rugarli, E. I. et al.; Bergami, M.; Langer, T.: Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy. EMBO Mol Med 11 (1), S. e9288 (2018)